From the last Q
"The Company understands the high level of interest of shareholders in the outcomes of the completed clinical trials. Trials such as BIT225-011 that include longitudinal analyses of a multitude of immunological markers involve complex, time-consuming modeling and consultation with relevant experts. Good progress is being made and the Company looks forward to reporting results during the second quarter of 2024."
It's what I am waiting for anyway.
Although I am of course aware that "the coming weeks" was the original target about 9 months ago.
EB
- Forums
- ASX - By Stock
- $10 Billion Deal
From the last Q "The Company understands the high level of...
-
-
- There are more pages in this discussion • 258 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add BIT (ASX) to my watchlist
(20min delay)
|
|||||
Last
1.9¢ |
Change
0.000(0.00%) |
Mkt cap ! $17.14M |
Open | High | Low | Value | Volume |
1.9¢ | 1.9¢ | 1.9¢ | $710 | 37.38K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
11 | 1609665 | 1.9¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
2.0¢ | 80000 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
10 | 1414801 | 0.019 |
12 | 2341165 | 0.018 |
5 | 688000 | 0.017 |
11 | 1524225 | 0.016 |
4 | 660000 | 0.015 |
Price($) | Vol. | No. |
---|---|---|
0.020 | 80000 | 1 |
0.021 | 500476 | 4 |
0.022 | 600000 | 2 |
0.023 | 307000 | 2 |
0.024 | 255035 | 3 |
Last trade - 10.53am 12/11/2024 (20 minute delay) ? |
Featured News
BIT (ASX) Chart |
The Watchlist
3DA
AMAERO INTERNATIONAL LTD
Hank Holland, Executive Chairman and CEO
Hank Holland
Executive Chairman and CEO
Previous Video
Next Video
SPONSORED BY The Market Online